 Mesothelioma
"Mesothelioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
| Descriptor ID |
D008654
|
| MeSH Number(s) |
C04.557.470.035.510 C04.557.470.660.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesothelioma".
Below are MeSH descriptors whose meaning is more specific than "Mesothelioma".
This graph shows the total number of publications written about "Mesothelioma" by people in this website by year, and whether "Mesothelioma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 0 | 1 | | 1982 | 1 | 1 | 2 | | 1983 | 1 | 0 | 1 | | 1984 | 1 | 0 | 1 | | 1989 | 1 | 1 | 2 | | 1990 | 1 | 0 | 1 | | 1992 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 1995 | 1 | 2 | 3 | | 1996 | 1 | 0 | 1 | | 1998 | 3 | 0 | 3 | | 1999 | 2 | 0 | 2 | | 2000 | 2 | 0 | 2 | | 2001 | 3 | 0 | 3 | | 2002 | 4 | 0 | 4 | | 2003 | 1 | 0 | 1 | | 2004 | 6 | 2 | 8 | | 2005 | 8 | 0 | 8 | | 2006 | 6 | 1 | 7 | | 2007 | 3 | 0 | 3 | | 2008 | 7 | 1 | 8 | | 2009 | 6 | 0 | 6 | | 2010 | 5 | 2 | 7 | | 2011 | 8 | 1 | 9 | | 2012 | 13 | 0 | 13 | | 2013 | 10 | 1 | 11 | | 2014 | 8 | 1 | 9 | | 2015 | 10 | 0 | 10 | | 2016 | 15 | 1 | 16 | | 2017 | 6 | 1 | 7 | | 2018 | 16 | 1 | 17 | | 2019 | 11 | 0 | 11 | | 2020 | 1 | 0 | 1 | | 2021 | 4 | 0 | 4 | | 2022 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Mesothelioma" by people in Profiles.
-
Carbone M, Pass HI, Ak G, Alexander HR, Baas P, Baumann F, Blakely AM, Bueno R, Bzura A, Cardillo G, Churpek JE, Dianzani I, De Rienzo A, Emi M, Emri S, Felley-Bosco E, Fennell DA, Flores RM, Grosso F, Hayward NK, Hesdorffer M, Hoang CD, Johansson PA, Kindler HL, Kittaneh M, Krausz T, Mansfield A, Metintas M, Minaai M, Mutti L, Nielsen M, O'Byrne K, Opitz I, Pastorino S, Pentimalli F, de Perrot M, Pritchard A, Ripley RT, Robinson B, Rusch V, Taioli E, Takinishi Y, Tanji M, Tsao AS, Tuncer AM, Walpole S, Wolf A, Yang H, Yoshikawa Y, Zolondick A, Schrump DS, Hassan R. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations. J Thorac Oncol. 2022 07; 17(7):873-889.
-
Carlson B, Harmath C, Turaga K, Kindler HL, Armato SG, Straus C. The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review. Abdom Radiol (NY). 2022 05; 47(5):1725-1740.
-
Kindler HL. Systemic Therapy for Mesothelioma: Turning the Corner. JCO Oncol Pract. 2022 06; 18(6):e843-e845.
-
Armato SG, Nowak AK, Francis RJ, Katz SI, Kholmatov M, Blyth KG, Gudmundsson E, Kidd AC, Gill RR. Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2022 02; 164:76-83.
-
Kindler HL. Understanding the new therapeutic options for mesothelioma. Lancet Oncol. 2021 10; 22(10):1353-1355.
-
Yap TA, Nakagawa K, Fujimoto N, Kuribayashi K, Guren TK, Calabrò L, Shapira-Frommer R, Gao B, Kao S, Matos I, Planchard D, Chatterjee A, Jin F, Norwood K, Kindler HL. Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study. Lancet Respir Med. 2021 06; 9(6):613-621.
-
White MG, Eng OS. Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". Br J Cancer. 2021 03; 124(6):1179-1180.
-
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. 2020 06 01; 126(11):2547-2552.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Ann Surg Oncol. 2020 Jun; 27(6):1774-1779.
-
Mirzapoiazova T, Pozhitkov A, Nam A, Mambetsariev I, Nelson MS, Tan YC, Zhang K, Raz D, Singhal S, Nasser MW, Kulkarni P, Batra SK, Sattler M, Salgia R. Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines. Int J Oncol. 2020 07; 57(1):80-86.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|